Invasive fungal infections (IFIs) pose the most serious infectious risk to patients with
hematologic malignancies and in those undergoing hematopoietic stem cell transplantation …

Invasive fungal infections (IFIs) represent significant complications in patients with
hematological malignancies. Chemoprevention of IFIs may be important in this setting, but …

The risks for invasive fungal infections, particularly mould infections such as invasive
aspergillosis, among hematopoietic stem cell transplant (HSCT) recipients are linked to the …

Objective: Patients with hematologic malignancies are at substantial risk of developing
invasive fungal infections (IFI) that are associated with substantial morbidity and mortality …

There is a strong argument for the use of antifungal prophylaxis in high‐risk patients given
the significant mortality associated with invasive fungal disease, the late identification of …

Invasive fungal disease (IFD), predominantly aspergillosis, is associated with significant
morbidity and mortality in immunocompromised patients, especially those with …

Invasive fungal infection (IFI) is associated with significant morbidity and mortality in patients
with hematologic malignancies. There have been significant changes in the epidemiology …

Invasive fungal infection (IFI) is a persistent problem among critically ill and
immunocompromised patients, especially hematopoietic stem cell transplant or solid organ …

Patients with acute leukemia and hematopoietic stem cell transplant recipients are at risk of
a spectrum of invasive fungal diseases corresponding to the type and intensity of …

In recipients of hematopoietic stem cell transplants (HSCTs), the mortality associated with
invasive fungal infections (IFIs) remains high, despite the introduction of broad‐spectrum …